Switch to:
Also traded in: Germany, Switzerland, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.63
CERN's Cash-to-Debt is ranked lower than
79% of the 1921 Companies
in the Global Health Information Services industry.

( Industry Median: 10.13 vs. CERN: 0.63 )
Ranked among companies with meaningful Cash-to-Debt only.
CERN' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.5  Med: 1.47 Max: 10.9
Current: 0.63
0.5
10.9
Equity-to-Asset 0.70
CERN's Equity-to-Asset is ranked higher than
67% of the 1830 Companies
in the Global Health Information Services industry.

( Industry Median: 0.60 vs. CERN: 0.70 )
Ranked among companies with meaningful Equity-to-Asset only.
CERN' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.46  Med: 0.61 Max: 0.79
Current: 0.7
0.46
0.79
Interest Coverage N/A
CERN's Interest Coverage is ranked higher than
70% of the 1467 Companies
in the Global Health Information Services industry.

( Industry Median: 173.79 vs. CERN: N/A )
Ranked among companies with meaningful Interest Coverage only.
CERN' s Interest Coverage Range Over the Past 10 Years
Min: 17.1  Med: 76.09 Max: 203.4
Current: N/A
17.1
203.4
Piotroski F-Score: 6
Altman Z-Score: 9.41
Beneish M-Score: -2.99
WACC vs ROIC
7.64%
15.57%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating Margin % 18.99
CERN's Operating Margin % is ranked higher than
85% of the 1862 Companies
in the Global Health Information Services industry.

( Industry Median: 4.84 vs. CERN: 18.99 )
Ranked among companies with meaningful Operating Margin % only.
CERN' s Operating Margin % Range Over the Past 10 Years
Min: 13.43  Med: 19.21 Max: 22.43
Current: 18.99
13.43
22.43
Net Margin % 13.27
CERN's Net Margin % is ranked higher than
80% of the 1863 Companies
in the Global Health Information Services industry.

( Industry Median: 3.19 vs. CERN: 13.27 )
Ranked among companies with meaningful Net Margin % only.
CERN' s Net Margin % Range Over the Past 10 Years
Min: 8.36  Med: 13.05 Max: 15.44
Current: 13.27
8.36
15.44
ROE % 15.88
CERN's ROE % is ranked higher than
75% of the 1803 Companies
in the Global Health Information Services industry.

( Industry Median: 6.16 vs. CERN: 15.88 )
Ranked among companies with meaningful ROE % only.
CERN' s ROE % Range Over the Past 10 Years
Min: 12.37  Med: 14.53 Max: 16.32
Current: 15.88
12.37
16.32
ROA % 11.16
CERN's ROA % is ranked higher than
82% of the 1927 Companies
in the Global Health Information Services industry.

( Industry Median: 2.92 vs. CERN: 11.16 )
Ranked among companies with meaningful ROA % only.
CERN' s ROA % Range Over the Past 10 Years
Min: 7.98  Med: 10.63 Max: 12.18
Current: 11.16
7.98
12.18
ROC (Joel Greenblatt) % 47.59
CERN's ROC (Joel Greenblatt) % is ranked higher than
62% of the 1883 Companies
in the Global Health Information Services industry.

( Industry Median: 23.13 vs. CERN: 47.59 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
CERN' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 36.87  Med: 48.76 Max: 73.16
Current: 47.59
36.87
73.16
3-Year Revenue Growth Rate 19.10
CERN's 3-Year Revenue Growth Rate is ranked higher than
82% of the 1454 Companies
in the Global Health Information Services industry.

( Industry Median: 5.30 vs. CERN: 19.10 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
CERN' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 5.8  Med: 16.7 Max: 29.6
Current: 19.1
5.8
29.6
3-Year EBITDA Growth Rate 20.30
CERN's 3-Year EBITDA Growth Rate is ranked higher than
70% of the 1210 Companies
in the Global Health Information Services industry.

( Industry Median: 8.40 vs. CERN: 20.30 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
CERN' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -11.9  Med: 16.6 Max: 74.1
Current: 20.3
-11.9
74.1
3-Year EPS without NRI Growth Rate 17.90
CERN's 3-Year EPS without NRI Growth Rate is ranked higher than
65% of the 1098 Companies
in the Global Health Information Services industry.

( Industry Median: 7.70 vs. CERN: 17.90 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
CERN' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -68.2  Med: 19.5 Max: 448.5
Current: 17.9
-68.2
448.5
GuruFocus has detected 2 Warning Signs with Cerner Corp $CERN.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» CERN's 10-Y Financials

Financials (Next Earnings Date: 2017-05-09 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2016

CERN Guru Trades in Q2 2016

Joel Greenblatt 19,163 sh (New)
George Soros 10,800 sh (New)
Manning & Napier Advisors, Inc 8,496,202 sh (+22.51%)
Vanguard Health Care Fund 16,949,730 sh (unchged)
PRIMECAP Management 20,000 sh (unchged)
Steven Cohen Sold Out
Jim Simons Sold Out
Frank Sands 11,518,519 sh (-5.72%)
Murray Stahl 9,479 sh (-15.12%)
Paul Tudor Jones 21,608 sh (-19.61%)
Ray Dalio 54,000 sh (-35.20%)
» More
Q3 2016

CERN Guru Trades in Q3 2016

Jim Simons 748,404 sh (New)
Jeremy Grantham 1,285,818 sh (New)
Paul Tudor Jones 31,283 sh (+44.78%)
PRIMECAP Management 20,000 sh (unchged)
George Soros Sold Out
Vanguard Health Care Fund 16,772,630 sh (-1.04%)
Manning & Napier Advisors, Inc 8,197,607 sh (-3.51%)
Frank Sands 10,775,077 sh (-6.45%)
Murray Stahl 8,177 sh (-13.74%)
Ray Dalio 31,900 sh (-40.93%)
Joel Greenblatt 10,926 sh (-42.98%)
» More
Q4 2016

CERN Guru Trades in Q4 2016

Jeff Auxier 35,975 sh (New)
Third Avenue Management 408,707 sh (New)
Arnold Van Den Berg 333,386 sh (New)
Joel Greenblatt 166,304 sh (+1422.09%)
Ray Dalio 249,175 sh (+681.11%)
Jim Simons 1,252,504 sh (+67.36%)
Murray Stahl 10,397 sh (+27.15%)
Vanguard Health Care Fund 16,918,530 sh (+0.87%)
Jeremy Grantham 1,291,903 sh (+0.47%)
PRIMECAP Management 20,000 sh (unchged)
Manning & Napier Advisors, Inc 3,870,904 sh (-52.78%)
Paul Tudor Jones 12,246 sh (-60.85%)
Frank Sands 3,123,675 sh (-71.01%)
» More
Q1 2017

CERN Guru Trades in Q1 2017

Martin Whitman 372,839 sh (New)
Arnold Van Den Berg 327,066 sh (-1.90%)
Manning & Napier Advisors, Inc 1,775,382 sh (-54.14%)
» More
» Details

Insider Trades

Latest Guru Trades with CERN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Application Software » Health Information Services    NAICS: 519190    SIC: 8099
Compare:NYSE:VEEV, NAS:ATHN, NAS:MDSO, NAS:HQY, NAS:WBMD, NAS:INOV, NAS:PINC, NYSE:EVH, NAS:OMCL, NYSE:TDOC, NAS:QSII, NAS:HSTM, NAS:NH, OTCPK:PMCUF, NAS:CPSI, NAS:RCM, NAS:TRHC, OTCPK:SNBP, OTCPK:COGZF, OTCPK:CNAB » details
Traded in other countries:CRE.Germany, CERN.Switzerland, 0R00.UK,
Headquarter Location:USA
Cerner Corp is a supplier of health care information technology, and offers software, professional services, medical device integration, remote hosting and employer health and wellness services.

Cerner is a top-tier healthcare information technology supplier that helps to eliminate errors and improve efficiency within complex healthcare organizations. The company provides a wide range of software, hardware, and services to more than 9,000 facilities globally and has a footprint in roughly 30% of all U.S. hospitals.

Guru Investment Theses on Cerner Corp

Third Avenue Management Comments on Cerner - Feb 01, 2017

Cerner (NASDAQ:CERN) is a leading health care information technology company. We have long admired Cerner as it is a well-financed compounder, having compounded book value at an average rate of 16% over the past 10 years. Delays in customer adoption of healthcare Information Technology (IT) systems as regulatory mandates have lengthened, exacerbated by concerns about potential changes to the ACA and the impact on healthcare IT spend, have negatively pressured Cerner's common stock price down from over $67 to our initial purchase cost of approximately $48, giving us an opportunity to acquire shares of Cerner common stock at an attractive valuation.

Healthcare IT has been in the sweet spot of spending for hospitals as regulatory reform and increasingly complex regulatory requirements have driven a greater need for IT solutions. The ACA and Health Information Technology Economic and Clinical Health Act (HITECH) were established to transition the U.S. healthcare system from fee-for-service towards value-based outcomes, i.e., incentivizing hospitals and providers for increasing quality of care and patient outcomes rather than the volume of procedures performed. As part of this initiative, electronic health records systems were required and analytics and data collection to monitor outcomes is increasing. Cerner is one of the market leaders in these systems. Similar to other IT companies, services and software for the installed base of systems generates high-margin recurring revenue. Further, many legacy systems are in need of upgrades to enable them to meet the new regulatory requirements. Given its market leading position, Cerner has been gaining share and is well-positioned to continue to take share. In addition, there has been consolidation within the industry, including some vendors discontinuing products.

While uncertainty remains regarding the ultimate resolution of the ACA, we believe the benefit of increased efficiencies that enhanced IT systems provide, along with increasing use cases, e.g., population health, will continue to bode well for Cerner's business, enabling the company to grow and compound value over the longer-term.

From Third Avenue Management (Trades, Portfolio)'s fourth calendar quarter 2016 shareholder letter.

Check out Third Avenue Management,Martin Whitman latest stock trades

Top Ranked Articles about Cerner Corp

Cerner Executives Earn ACHE’s Top Credential for Health Care Management
St. Joseph’s Healthcare System Selects Cerner’s Clinical, Financial and Population Health Management IT System
Cerner to Release First Quarter 2017 Earnings Results April 27
Pomona Valley Hospital Medical Center Selects Cerner Millennium
Maury Regional Health Selects Cerner’s Integrated Health IT System

KANSAS CITY, Mo. and COLUMBIA, Tenn., March 22, 2017 (GLOBE NEWSWIRE) -- Maury Regional Health has selected Cerner, a global leader in health care technology, to implement an enterprisewide electronic health record (EHR) system across its three hospitals and more than 25 outpatient facilities. The Cerner system will displace MEDITECH® in the hospital setting and NextGen® Healthcare in the ambulatory facilities.  
This year, the health system’s 255-bed Maury Regional Medical Center, the largest medical center between Nashville and Huntsville, was ranked No. 1 in Tennessee by CareChex® for overall hospital care in the area of medical excellence. “Cerner will provide our organization with enhanced capabilities that will be beneficial for providers and patients,” said Maury Regional Health CEO Alan Watson. “We are excited to unveil Cerner’s integrated health IT platform that will support our care teams across the continuum and unleash the potential of sophisticated functionality.” The Cerner Millennium® EHR and integrated revenue cycle management solutions combine clinical and financial information within a single platform. This results in a Clinically Driven Revenue Cycle™ designed to help clinicians and staff update the billing process throughout the patient’s visit, enhance clinical documentation to help improve reimbursement and limit claims errors. The agreement also includes Cerner Transaction Services, a suite of core services that helps reduce traditional bolt-on solutions. The services provide recommended practice workflows across Cerner revenue cycle management solutions to prevent redundant tasks and manage manual intervention. Through its remote-hosting offering, Cerner will manage and support Maury Regional’s EHR and deliver clinical data from its Kansas City-based data center. “Maury Regional is in a highly competitive and consolidating health care market, and we are proud to provide a robust platform that will support the organization as its leadership works toward continued accomplishments, independence and market strength,” said Cerner President Zane Burke. “Together, we’ll establish more connected health system that places the person at the center of the care journey.” About Maury Regional Health
Serving more than 200,000 people across southern Middle Tennessee, Maury Regional Medical Center, a 255-bed facility, is the largest medical center between Nashville and Huntsville and has been evaluated by outside organizations and compared to some of the most respected medical centers in the country. For 2017, Maury Regional Medical Center was ranked number one in Tennessee for overall hospital care in the area of medical excellence by CareChex.com®, — an information service of Quantros, Inc. The medical center offers a wide range of advanced services including an accredited heart program, neonatal intensive care and cancer center. In addition to Maury Regional Medical Center, Maury Regional Health includes Marshall Medical Center in Lewisburg, Wayne Medical Center in Waynesboro, Lewis Health Center in Hohenwald, Family Health Group physician practices, as well as additional facilities across southern Middle Tennessee. For more information, visit MauryRegional.com.  About Cerner
Cerner’s health information technologies connect people, information and systems at more than 25,000 provider facilities worldwide. Recognized for innovation, Cerner solutions assist clinicians in making care decisions and enable organizations to manage the health of populations. The company also offers an integrated clinical and financial system to help health care organizations manage revenue, as well as a wide range of services to support clients’ clinical, financial and operational needs. Cerner’s mission is to contribute to the systemic improvement of health care delivery and the health of communities. CERN. For more information about Cerner, visit cerner.com, read our blog at blogs.cerner.com, connect with us on Twitter at twitter.com/cerner and on Facebook at facebook.com/cerner. Our website, blog, Twitter account and Facebook page contain a significant amount of information about Cerner, including financial and other information for investors.
Cerner
Angela Vogen
Public Relations
816-571-9189
[email protected]

Read more...
Arnold Van Den Berg Invests in 4 New Buys in 4th Quarter Guru purchases shares of Cerner, Occidental Petroleum, Atkore, CVS
Arnold Van Den Berg (Trades, Portfolio), founder of Century Management, added four new positions to the portfolio in the fourth quarter. Read more...
Cerner, State and Local Leaders Commemorate Innovations With Ribbon-Cutting
KANSAS CITY, Mo., March 09, 2017 (GLOBE NEWSWIRE) -- Cerner, a global leader in health care technology, hosted a ribbon-cutting ceremony to celebrate the opening of the first two towers at Innovations, the organization’s newest campus in the Kansas City area.
Photos accompanying this announcement are available athttp://www.globenewswire.com/NewsRoom/AttachmentNg/e79fa634-2240-4991-a9f6-1382bee8d843http://www.globenewswire.com/NewsRoom/AttachmentNg/8de9223c-8228-47c7-b9d5-810317c094efCerner President Zane Burke and Cerner Executive Vice President and Chief Operating Officer Mike Nill were joined by Missouri Gov. Eric Greitens and Kansas City Mayor Sly James to commemorate the milestone in the multi-phased project. The office is expected to create capacity for up to 16,000 new jobs by 2025 and is the largest economic development project in the history of the state.“This project is a tangible reflection of Cerner’s growth and the next generation of health care innovations,” said Mike Nill, vice president and COO, Cerner. “The campus name and design features symbolize our commitment to develop solutions and services that will advance and improve the ever-changing health care industry. The work performed in these buildings will continue shaping the future of health care for both providers and patients.”This will be Cerner’s seventh campus in the Kansas City area. The first two towers house 3,000 Cerner engineering associates and were designed with open and collaborative meeting spaces to encourage creativity, dynamic thinking and community.
About Cerner
Cerner’s health information technologies connect people, information and systems at more than 25,000 provider facilities worldwide. Recognized for innovation, Cerner solutions assist clinicians in making care decisions and enable organizations to manage the health of populations. The company also offers an integrated clinical and financial system to help health care organizations manage revenue, as well as a wide range of services to support clients’ clinical, financial and operational needs. Cerner’s mission is to contribute to the systemic improvement of health care delivery and the health of communities. CERN. For more information about Cerner, visit cerner.com, read our blog at blogs.cerner.com, connect with us on Twitter at twitter.com/cerner and on Facebook at facebook.com/cerner. Our website, blog, Twitter account and Facebook page contain a significant amount of information about Cerner, including financial and other information for investors.
Media Contact:
Cerner: Angela Vogen, [email protected], 816-571-9189

Read more...
Palmetto Health Expands Cerner Health IT System

KANSAS CITY, Mo. and COLUMBIA, S.C., March 07, 2017 (GLOBE NEWSWIRE) -- Longtime Cerner client Palmetto Health has selected Cerner, a global leader in health care technology, to expand Millennium Revenue Cycle™ across four of its acute facilities. Integration with the existing electronic health record (EHR) will result in a Clinically Driven Revenue Cycle™.
Inclusive of Cerner Transaction Services and Cerner Acute Case Management, the patient-centric revenue cycle management platform is designed to integrate clinical and financial workflows to achieve a single patient record and take advantage of clinical automation that helps reduce traditional (i.e., manual) revenue cycle functions. In providing quality care, Palmetto Health clinicians and staff will have access to patient information when they need it without logging in and out of systems. System integration supports users to consistently perform the right activities at the right time, which can result in successful denial avoidance enabling a successful revenue cycle. “Cerner delivers the foundational elements we need to achieve an integrated, enterprisewide Millennium environment to help us work toward better patient experiences, team member experiences and financial results,” said Benjamin M. Cunningham, Jr., system vice president of Finance, Palmetto Health. Cerner’s Clinically Driven Revenue Cycle is designed to enable clinicians and staff to update the billing process throughout the patient’s visit, enhance clinical documentation to help improve reimbursement and limit claims errors. Patients will benefit by having direct access to their clinical results and a streamlined experience across these facilities, including visibility into their financial liability from a single source. “We’re proud to have demonstrated our commitment to Palmetto over the years and to be selected to transition the system to a platform that incorporates patient financial information with clinical data,” said Jeff Hurst, senior vice president, Cerner Revenue Cycle Management and president of Cerner RevWorks. “We look forward to working with Palmetto to develop an even stronger health IT foundation.” About Cerner
Cerner’s health information technologies connect people, information and systems at more than 25,000 provider facilities worldwide. Recognized for innovation, Cerner solutions assist clinicians in making care decisions and enable organizations to manage the health of populations. The company also offers an integrated clinical and financial system to help health care organizations manage revenue, as well as a wide range of services to support clients’ clinical, financial and operational needs. Cerner’s mission is to contribute to the systemic improvement of health care delivery and the health of communities. CERN. For more information about Cerner, visit cerner.com, read our blog at blogs.cerner.com, connect with us on Twitter at twitter.com/cerner and on Facebook at facebook.com/cerner. Our website, blog, Twitter account and Facebook page contain a significant amount of information about Cerner, including financial and other information for investors.
Media Contact:
Cerner: Angela Vogen, [email protected], 816-571-9189

Read more...
Cerner Announces Appointment of Julie Gerberding to Its Board of Directors

KANSAS CITY, Mo., March 06, 2017 (GLOBE NEWSWIRE) -- Cerner Corporation (NASDAQ:CERN) announced today that former Sen. John C. “Jack” Danforth notified the Board of Directors he does not intend to stand for re-election to the Board at Cerner’s 2017 annual shareholder meeting to be held in May 2017, as he plans to retire effective immediately prior to the meeting. Cerner further announced that Dr. Julie Gerberding has been appointed to the company’s Board of Directors, effective March 3. Dr. Gerberding, 61, is executive vice president for strategic communications, global public policy and population health of Merck & Co, Inc., a role she assumed in December 2015 after serving as president of Merck Vaccines since 2010. Dr. Gerberding fills a newly created Class I Director seat.
With this appointment, Cerner’s board now has 10 members, with eight of them, including Dr. Gerberding, being external and independent. Dr. Gerberding will stand for re-election at Cerner’s 2017 annual shareholder meeting. “I want to thank Jack Danforth for his extraordinary service dating back to 1996,” said Neal Patterson, Cerner’s chairman, CEO, and co-founder. “It’s an honor to welcome Dr. Gerberding to our outstanding Board as our industry moves to a new era focused on using data-driven insights to improve health outcomes across populations. Her extensive experience as a clinician and business leader who has navigated complex policy and regulatory environments will be a great asset to Cerner.” Prior to joining Merck, Dr. Gerberding served as director of the U.S. Centers for Disease Control and Prevention (CDC) and before that served as director of the Division of Healthcare Quality Promotion. Before joining the CDC, Dr. Gerberding was a tenured faculty member in Infectious Diseases at the University of California at San Francisco (UCSF).  She continues as an Adjunct Associate Clinical Professor of Medicine at UCSF. About Cerner
Cerner’s health information technologies connect people, information and systems at more than 25,000 facilities worldwide. Recognized for innovation, Cerner® solutions assist clinicians in making care decisions and enable organizations to manage the health of populations. The company also offers an integrated clinical and financial system to help health care organizations manage revenue, as well as a wide range of services to support clients’ clinical, financial and operational needs. Cerner’s mission is to contribute to the systemic improvement of health care delivery and the health of communities.  CERN. For more information about Cerner, visit cerner.com, read our blog at blogs.cerner.com, connect with us on Twitter at twitter.com/cerner and on Facebook at facebook.com/cerner. Our website, blog, Twitter account and Facebook page contain a significant amount of information about Cerner, including financial and other information for investors.
Cerner Media Contact: Dan Smith, (816) 678-9301, [email protected]
Cerner Investors Contact: Allan Kells, (816) 201-2445, [email protected]

Read more...
Jeff Auxier Buys Cerner, Yum China and Granite Construction Guru releases quarterly portfolio
Auxier Asset Management President and CEO Jeff Auxier (Trades, Portfolio) gained three new holdings in the final quarter of 2016. They are Cerner Corp. (NASDAQ:CERN), Yum China Holdings Inc. (NYSE:YUMC) and Granite Construction Inc. (NYSE:GVA). Read more...

Ratios

vs
industry
vs
history
PE Ratio 32.05
CERN's PE Ratio is ranked lower than
60% of the 1245 Companies
in the Global Health Information Services industry.

( Industry Median: 25.80 vs. CERN: 32.05 )
Ranked among companies with meaningful PE Ratio only.
CERN' s PE Ratio Range Over the Past 10 Years
Min: 14.92  Med: 36.53 Max: 54.94
Current: 32.05
14.92
54.94
Forward PE Ratio 23.70
CERN's Forward PE Ratio is ranked lower than
59% of the 535 Companies
in the Global Health Information Services industry.

( Industry Median: 20.20 vs. CERN: 23.70 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 32.05
CERN's PE Ratio without NRI is ranked lower than
59% of the 1229 Companies
in the Global Health Information Services industry.

( Industry Median: 26.21 vs. CERN: 32.05 )
Ranked among companies with meaningful PE Ratio without NRI only.
CERN' s PE Ratio without NRI Range Over the Past 10 Years
Min: 14.53  Med: 36.57 Max: 54.94
Current: 32.05
14.53
54.94
Price-to-Owner-Earnings 33.79
CERN's Price-to-Owner-Earnings is ranked lower than
66% of the 724 Companies
in the Global Health Information Services industry.

( Industry Median: 22.94 vs. CERN: 33.79 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
CERN' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 18.58  Med: 35.96 Max: 104.7
Current: 33.79
18.58
104.7
PB Ratio 5.31
CERN's PB Ratio is ranked lower than
70% of the 1789 Companies
in the Global Health Information Services industry.

( Industry Median: 2.97 vs. CERN: 5.31 )
Ranked among companies with meaningful PB Ratio only.
CERN' s PB Ratio Range Over the Past 10 Years
Min: 2.05  Med: 4.62 Max: 6.92
Current: 5.31
2.05
6.92
PS Ratio 4.24
CERN's PS Ratio is ranked lower than
68% of the 1780 Companies
in the Global Health Information Services industry.

( Industry Median: 2.34 vs. CERN: 4.24 )
Ranked among companies with meaningful PS Ratio only.
CERN' s PS Ratio Range Over the Past 10 Years
Min: 1.67  Med: 4.39 Max: 7.51
Current: 4.24
1.67
7.51
Price-to-Free-Cash-Flow 52.94
CERN's Price-to-Free-Cash-Flow is ranked lower than
79% of the 677 Companies
in the Global Health Information Services industry.

( Industry Median: 24.32 vs. CERN: 52.94 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
CERN' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 21.57  Med: 48.93 Max: 1841.39
Current: 52.94
21.57
1841.39
Price-to-Operating-Cash-Flow 17.58
CERN's Price-to-Operating-Cash-Flow is ranked higher than
50% of the 856 Companies
in the Global Health Information Services industry.

( Industry Median: 17.68 vs. CERN: 17.58 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
CERN' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 9.31  Med: 19.58 Max: 33.32
Current: 17.58
9.31
33.32
EV-to-EBIT 21.25
CERN's EV-to-EBIT is ranked lower than
56% of the 1770 Companies
in the Global Health Information Services industry.

( Industry Median: 17.68 vs. CERN: 21.25 )
Ranked among companies with meaningful EV-to-EBIT only.
CERN' s EV-to-EBIT Range Over the Past 10 Years
Min: 9.1  Med: 22.8 Max: 36.7
Current: 21.25
9.1
36.7
EV-to-EBITDA 13.74
CERN's EV-to-EBITDA is ranked higher than
53% of the 1910 Companies
in the Global Health Information Services industry.

( Industry Median: 13.76 vs. CERN: 13.74 )
Ranked among companies with meaningful EV-to-EBITDA only.
CERN' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.7  Med: 14.4 Max: 25.2
Current: 13.74
5.7
25.2
PEG Ratio 1.98
CERN's PEG Ratio is ranked higher than
50% of the 567 Companies
in the Global Health Information Services industry.

( Industry Median: 1.98 vs. CERN: 1.98 )
Ranked among companies with meaningful PEG Ratio only.
CERN' s PEG Ratio Range Over the Past 10 Years
Min: 0.78  Med: 2.2 Max: 3.81
Current: 1.98
0.78
3.81
Shiller PE Ratio 54.29
CERN's Shiller PE Ratio is ranked lower than
66% of the 291 Companies
in the Global Health Information Services industry.

( Industry Median: 38.24 vs. CERN: 54.29 )
Ranked among companies with meaningful Shiller PE Ratio only.
CERN' s Shiller PE Ratio Range Over the Past 10 Years
Min: 34.87  Med: 71.36 Max: 94.06
Current: 54.29
34.87
94.06
Current Ratio 1.92
CERN's Current Ratio is ranked higher than
50% of the 1750 Companies
in the Global Health Information Services industry.

( Industry Median: 1.94 vs. CERN: 1.92 )
Ranked among companies with meaningful Current Ratio only.
CERN' s Current Ratio Range Over the Past 10 Years
Min: 1.92  Med: 2.69 Max: 5.16
Current: 1.92
1.92
5.16
Quick Ratio 1.90
CERN's Quick Ratio is ranked higher than
53% of the 1750 Companies
in the Global Health Information Services industry.

( Industry Median: 1.79 vs. CERN: 1.90 )
Ranked among companies with meaningful Quick Ratio only.
CERN' s Quick Ratio Range Over the Past 10 Years
Min: 1.82  Med: 2.63 Max: 5.12
Current: 1.9
1.82
5.12
Days Inventory 8.39
CERN's Days Inventory is ranked higher than
64% of the 1086 Companies
in the Global Health Information Services industry.

( Industry Median: 18.20 vs. CERN: 8.39 )
Ranked among companies with meaningful Days Inventory only.
CERN' s Days Inventory Range Over the Past 10 Years
Min: 7.15  Med: 13.98 Max: 19.85
Current: 8.39
7.15
19.85
Days Sales Outstanding 69.69
CERN's Days Sales Outstanding is ranked lower than
51% of the 1492 Companies
in the Global Health Information Services industry.

( Industry Median: 68.98 vs. CERN: 69.69 )
Ranked among companies with meaningful Days Sales Outstanding only.
CERN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 66.04  Med: 80.17 Max: 102.12
Current: 69.69
66.04
102.12
Days Payable 111.56
CERN's Days Payable is ranked higher than
81% of the 1330 Companies
in the Global Health Information Services industry.

( Industry Median: 43.37 vs. CERN: 111.56 )
Ranked among companies with meaningful Days Payable only.
CERN' s Days Payable Range Over the Past 10 Years
Min: 47.89  Med: 99.82 Max: 115.48
Current: 111.56
47.89
115.48

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -0.90
CERN's 3-Year Average Share Buyback Ratio is ranked higher than
64% of the 1148 Companies
in the Global Health Information Services industry.

( Industry Median: -2.60 vs. CERN: -0.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CERN' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -4  Med: -1.5 Max: 2.3
Current: -0.9
-4
2.3

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 11.59
CERN's Price-to-Tangible-Book is ranked lower than
79% of the 1488 Companies
in the Global Health Information Services industry.

( Industry Median: 4.38 vs. CERN: 11.59 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
CERN' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.33  Med: 5.42 Max: 11.43
Current: 11.59
1.33
11.43
Price-to-Intrinsic-Value-Projected-FCF 2.56
CERN's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
61% of the 771 Companies
in the Global Health Information Services industry.

( Industry Median: 1.97 vs. CERN: 2.56 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
CERN' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1.48  Med: 2.71 Max: 6.27
Current: 2.56
1.48
6.27
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.23
CERN's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
65% of the 124 Companies
in the Global Health Information Services industry.

( Industry Median: 1.45 vs. CERN: 1.23 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 0.97
CERN's Price-to-Median-PS-Value is ranked higher than
68% of the 1498 Companies
in the Global Health Information Services industry.

( Industry Median: 1.15 vs. CERN: 0.97 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
CERN' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.14  Med: 0.74 Max: 1.54
Current: 0.97
0.14
1.54
Price-to-Peter-Lynch-Fair-Value 2.00
CERN's Price-to-Peter-Lynch-Fair-Value is ranked lower than
58% of the 339 Companies
in the Global Health Information Services industry.

( Industry Median: 1.60 vs. CERN: 2.00 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
CERN' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.89  Med: 1.89 Max: 3.42
Current: 2
0.89
3.42
Price-to-Graham-Number 4.06
CERN's Price-to-Graham-Number is ranked lower than
70% of the 882 Companies
in the Global Health Information Services industry.

( Industry Median: 2.52 vs. CERN: 4.06 )
Ranked among companies with meaningful Price-to-Graham-Number only.
CERN' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.07  Med: 3.03 Max: 13.67
Current: 4.06
1.07
13.67
Earnings Yield (Greenblatt) % 4.71
CERN's Earnings Yield (Greenblatt) % is ranked higher than
61% of the 2521 Companies
in the Global Health Information Services industry.

( Industry Median: 3.23 vs. CERN: 4.71 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
CERN' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 2.7  Med: 4.4 Max: 11
Current: 4.71
2.7
11
Forward Rate of Return (Yacktman) % 17.58
CERN's Forward Rate of Return (Yacktman) % is ranked higher than
69% of the 773 Companies
in the Global Health Information Services industry.

( Industry Median: 10.33 vs. CERN: 17.58 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
CERN' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 1.5  Med: 17 Max: 22.8
Current: 17.58
1.5
22.8

More Statistics

Revenue (TTM) (Mil) $4,796
EPS (TTM) $ 1.84
Beta0.94
Short Percentage of Float7.12%
52-Week Range $47.01 - 67.50
Shares Outstanding (Mil)329.72

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 5,170 5,549 6,113
EPS ($) 2.50 2.74 3.03
EPS without NRI ($) 2.50 2.74 3.03
EPS Growth Rate
(Future 3Y To 5Y Estimate)
14.93%
Dividends per Share ($)
» More Articles for CERN

Headlines

Articles On GuruFocus.com
Cerner Executives Earn ACHE’s Top Credential for Health Care Management Apr 11 2017 
St. Joseph’s Healthcare System Selects Cerner’s Clinical, Financial and Population Health Apr 11 2017 
High Predictability Guru Stocks Apr 10 2017 
Cerner to Release First Quarter 2017 Earnings Results April 27 Apr 10 2017 
Pomona Valley Hospital Medical Center Selects Cerner Millennium Apr 03 2017 
Is the S&P 500 the Right Portfolio for You? Apr 03 2017 
Maury Regional Health Selects Cerner’s Integrated Health IT System Mar 22 2017 
Arnold Van Den Berg Invests in 4 New Buys in 4th Quarter Mar 13 2017 
Cerner, State and Local Leaders Commemorate Innovations With Ribbon-Cutting Mar 09 2017 
Palmetto Health Expands Cerner Health IT System Mar 07 2017 

More From Other Websites
Cerner Has Further to Go on the Upside Apr 17 2017
Cerner Executives Earn ACHE’s Top Credential for Health Care Management Apr 11 2017
St. Joseph’s Healthcare System Selects Cerner’s Clinical, Financial and Population Health... Apr 11 2017
Cerner to Release First Quarter 2017 Earnings Results April 27 Apr 10 2017
Which KC-area stocks had the best, worst March? Take a look Apr 03 2017
Pomona Valley Hospital Medical Center Selects Cerner Millennium Apr 03 2017
Cerner (CERN) Banks on RCM & PH Platforms, Competition Rife Mar 30 2017
Cerner tool saves lives, dollars by mitigating infection threat Mar 29 2017
Cerner helps Missouri town join drug monitoring program Mar 27 2017
ETFs with exposure to Cerner Corp. : March 27, 2017 Mar 27 2017
Cerner may benefit from VA's health record overhaul Mar 23 2017
Cerner (CERN) Up 2.5% Since Earnings Report: Can It Continue? Mar 23 2017
Maury Regional Health Selects Cerner’s Integrated Health IT System Mar 22 2017
Cerner Corp. :CERN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017 Mar 17 2017
Cerner: Tech can help reduce uninsured pains from ACA reform Mar 14 2017
Arnold Van Den Berg Invests in 4 New Buys in 4th Quarter Mar 13 2017
Cerner's new campus brings out the bells and whistles Mar 10 2017
Cerner, State and Local Leaders Commemorate Innovations With Ribbon-Cutting Mar 09 2017
Palmetto Health Expands Cerner Health IT System Mar 07 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)